Sitari Pharmaceuticals
About:
Sitari Pharmaceuticals is a biotechnology company developing treatments for multiple disease indications.
Top Investors: GlaxoSmithKline, Avalon Ventures
Description:
Sitari Pharmaceuticals is a operator of a biotechnology company intended to develop treatments for multiple disease indications with an initial focus in celiac disease.
Total Funding Amount:
$10M
Headquarters Location:
San Diego, California, United States
Founded Date:
2013-01-01
Founders:
Chaitan S. Khosla
Number of Employees:
Last Funding Date:
2013-11-22
IPO Status:
Private
Industries:
© 2025 bioDAO.ai